Clayman says the company's next 18 months are all about Zilretta, with further pipeline construction next up.
The company said adult women between the ages of 50 and 70 are most likely to share content on the social media platform.
The FDA approves osteoporosis drug; groups warn that latest healthcare bill would cut protections for pre-existing conditions; Dupixent gets PBM coverage
Fueled by innovation in new treatments, the underserved women's health market has begun to turn the proverbial corner. What took it so long?
The osteoporosis drug market is bracing for the advent of potentially game-changing treatments.
Only one new osteoporosis drug has been approved over the last six years.